Пошуковий запит: <.>K=КАФЕДРА ВНУТРІШНІХ ХВОРОБ № 2<.> |
Загальна кількість знайдених документів : 272
Показані документи с 1 за 20 |
|
1.
| Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure/T. A. Berezina, Z. Obradovic, E. Boxhammer, A. A. Berezin, M. Lichtenauer, A. E. Berezin // Journal of Clinical Medicine, 2023. т.Vol. 12,N N 6.-С.2231
|
2.
| Altered adipocytokine profile predicts early stage of left ventricular remodeling in hypertensive patients with type 2 diabetes mellitus/O. M. Bilovol, I. I. Knyazkova, O. V. Al-Travneh, M. V.Bogun, A. E. Berezin // Diabetes & Metabolic Syndrome-Clinical Research & Reviews, 2020. т.Vol. 14,N N 2.-С.P. 109-116
|
3.
| Altered immune pattern of circulating endothelial cell-derived micro vesicles predicts chronic heart failure development in patients with metabolic syndrome/A E. Berezin, A. Kremzer,T. Samura,T. Berezina // European Journal of Heart Failure, 2018. т.Vol. 20,N Suppl. S1.-С.95
|
4.
| Altered myokine profile and glycemic control in type 2 diabetes mellitus patients with heart failure/A. A. Berezin, Z. Obradovic, E. V. Novikov, I. M. Fuschtey, A. E. Berezin // European Journal of Heart Failure, 2023. т.Vol. 25
|
5.
| Altered number of apoptotic-modified endothelial cells originated micro vesicles predict phenotypes of heart failure/A. E. Berezin, А. А. Kremzer, I. Mozos. A. A. Berezin, D. Petrovic // European Journal of Heart Failure, 2019. т.Vol. 21.-С.P. 375-376
|
6.
| Altered signature of apoptotic endothelial cell-derived microvesicles predicts chronic heart failure phenotypes/A. E. Berezin, А. А. Kremzer, Т. A. Samura, T. A. Berezina // Biomarkers in Medicine, 2019. т.Vol. 13,N N 9.-С.P. 737-750
|
7.
| Association of growth-differentiation factor-15 with the number of circulating proangiogenic endothelial progenitor cells in patients with type 2 diabetes mellitus/A. E. Berezin, A. A. Kremzer, D. l. Petrovich, I. Mozos, A. A. Berezin // Biomedical Research And Therapy, 2018:Vol. 5,N N 7.-С.2480-2492
|
8.
| Berezin A. A. Irisin predicted heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus/A. Berezin, I. M. Fushtey, A. Berezin // Diabetes Technology & Therapeutics. -Нью-Йорк, 2022. т.Vol. 24.-С.A151-A151
|
9.
| Berezin A. A. Multidirectional changes in the levels of irisin and apelin predicted heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus/A. A. Berezin, I. M. Fushtey, A. E. Berezin // Diabetes Technology & Therapeutics. -Нью-Йорк, 2022. т.Vol. 24.-С.A150-A150
|
10.
| Berezin A. A. Predictive utility of apelin to nt-pro-brain natriuretic peptide ratio for heart failure with preserved ejection fraction among type 2/A. А. Berezin, I. M. Fushtey, A. E. Berezin // European Journal of Heart Failure, 2021. т.Vol. 23.-С.P. 26
|
11.
| Berezin A. A. The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure/A. А. Berezin, I. M. Fushtey, A. E. Berezin // Biomedicines. -Basel:MDPI AG, 2022. т.Vol. 10,N N 7.-С.1751
|
12.
| Berezin A. E. Altered adipocytokine profile predicts early stage of left ventricular remodeling in hypertensive patients with type 2 diabetes mellitus/O. M. Bilovol, I. I. Knyazkova, O. V. Al-Travneh, M. V.Bogun, A. E. Berezin // Diabetes & Metabolic Syndrome-Clinical Research & Reviews, 2019. т.Vol. 13,N N 4.-С.P. 2549-2556
|
13.
| Berezin A. E. Altered profile of circulating myokines as a predictor of poor prognosis in heart failure/A. E. Berezin, A. А. Berezin, S. P. Myrnyi // Transylvanian review:Center Transylvanian Studies, 2020. т.Vol. 27,N N 50.-С.P.15417-15422
|
14.
| Berezin A. E. Antigen-presenting cell-derived extracellular vesicles in accelerating atherosclerosis/A. E. Berezin, A. А. Berezin // Biomedical Research And Therapy:Ho Chi Minh City, 2021:Vol. 8,N N 3.-С.P. 4258-4265
|
15.
| Berezin A. E. Biomarker-based guideline-directed medical therapy of heart failure: the gap between guidelines and clinical practice/A. E. Berezin, A. А. Berezin // EMJ: Cardiology. -London:EMJ, 2021. т.Vol. 9.1,N October.-С.P. 51-60
|
16.
| Berezin A. E. Biomarkers in Heart Failure: From Research to Clinical Practice/A. E. Berezin, A. A. Berezin // Annals of Laboratory Medicine, 2023. т.Vol. 43,N N 3.-С.225-236
|
17.
| Berezin A. E. Can Osteoprotegerin be a Target of Therapy in Type 2 Diabetes Mellitus?/A. E. Berezin // Metabolomics: Open Access, 2016. т.Vol. 6,N N 2.-С.[рр. 5]
|
18.
| Berezin A. E. Cell-free long noncoding RNAs as predictive biomarkers for cardiovascular diseases/A. E. Berezin // International Journal of Cardiology, 2022. т.Vol. 359.-С.115-117
|
19.
| Berezin A. E. Challenging role of myokines in heart failure/A. E. Berezin, A. А. Berezin // Biomarkers Journal. -London:iMedPub LTD, 2020. т.Vol. 7,N N 1:2.-С.P. 1-5
|
20.
| Berezin A. E. Circulating Biomarkers in Heart Failure/A. E. Berezin // Advances in Experimental Medicine and Biology. -Cham:Springer, 2018. т.Vol. 1067:Heart Failure: From Research to Clinical Practice.-С.89-108
|
|
|
|
На головну сторінку сайту
E-бібліотека навчальних матеріалів
Електронний каталог бібліотеки ЗДМФУ
Стандартний